PolarityTE Inc., a biotechnology company developing and commercializing regenerative tissue products and biomaterials, has released data from studies looking at its SkinTE™ product for closure of diabetic...
CCRC receives financing
By
Elizabeth Newman
Oct 16, 2018
HJ Sims announced that it had closed $70.4 million in financing, $14 million in subordinate financing and $69.9 million in bond underwriting for Legacy Midtown Park in Dallas.
Admission and visitation policies among top potential legal pitfalls in new rule, expert says
By
Elizabeth Newman
Mar 22, 2017
Long-term care providers should pay special attention to their admission, visitation and grievance policies under the new requirements of participation rule from the Centers for Medicare & Medicaid Services,...
AI incorporated into claims
By
Elizabeth Newman
Feb 12, 2019
Change Healthcare said during the HIMSS show that its Claims Lifecycle Artificial Intelligence would be added to the company’s Intelligent Healthcare NetworkTM and financial solutions. The new system...
Facilities need better reviews of antibiotic use, expert says
By
Elizabeth Newman
Jun 01, 2013
Skilled nursing facility administrators need to do a complete review of antibiotics to better combat multi-drug resistant organisms, an infection control expert said in May.
Researchers: Be careful with assignment of irregular shifts
By
Elizabeth Newman
Jan 01, 2014
The children of single mothers working a nonstandard shift are more likely to engage in delinquent behaviors, according to a new analysis.
Cascade adds 15 facilities
By
Elizabeth Newman
May 14, 2019
Cascade Capital Group has bought 15 skilled nursing and assisted living facilities in two separate transactions at a total cost of $130 million.
Kwalu, Clorox team up for a clean finish
By
Elizabeth Newman
Aug 05, 2015
Long-term care furniture company Kwalu and Clorox Healthcare have announced a joint marketing venture that will promote disinfectants on non-porous furnishings.
FDA approves first biosimilar treatment
By
Elizabeth Newman
Apr 06, 2015
The Food and Drug Administration approved its first biosimilar product in March, opening the door for more costly drug alternatives.
Alleged $250 million overbilling charges in hospices disputed , experts say
By
Elizabeth Newman
Apr 07, 2016
A recent HHS Office of Inspector General report calling out hospices for billing $250 million inappropriately in 2012 doesn’t tell the whole story, an attorney said this week.